Sign in
4

Changes in Ownership

Lipocine Inc. Filed Acc 0001638599-18-001327

Options or other derivatives

  • President and CEO acquired 440,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Patel Mahesh V. President and CEO 2018-12-04 Grant or award · Restricted stock unit +290,000 290,000 D
Patel Mahesh V. President and CEO 2018-12-04 Grant or award · Stock Option (Right to Buy) +150,000 $1.46 $219,000 150,000 D
Loading xslF345X03/doc4_5817.xml…